A new generation of electronic cigarettes is quietly transforming nicotine and cannabis consumption into something that resembles a mobile game with a payout. These so-called smart vaping devices connect to smartphone applications, track every puff a user takes, and dispense tangible rewards for the act of vaping itself, including points, free refill cartridges, and even cryptocurrency. Researchers at the Medical University of South Carolina Hollings Cancer Center are now warning that this fusion of addictive substances with financial incentives, gamification, and artificial intelligence represents a genuinely novel public health threat, one that could deepen nicotine dependence, entice adolescents, and actively undermine decades of progress in smoking cessation. In a perspective published in the New England Journal of Medicine, the Hollings team argues that regulators and clinicians need to confront these products now, while they remain a niche market, rather than after they have become an entrenched feature of the vaping landscape.
The perspective examines two recently introduced products that exemplify the trend. The first, Puffpaw, is a nicotine vaping device that has been marketed, remarkably, as an aid for quitting e-cigarettes, even as it ties rewards to continued use. The second, Gudtrip, is a cannabis vaping device that explicitly positions itself at the intersection of artificial intelligence, cryptocurrency, and cannabis culture. Both products pair the physical device with a smartphone app that monitors user behavior and converts vaping activity into redeemable value. What struck the researchers most forcefully was the fundamental inversion of established addiction treatment principles embedded in this design. In evidence-based substance use treatment, clinicians work to help patients discover sources of reward that are not connected to drug use. These devices do precisely the opposite, layering additional reward onto a behavior that is already powerfully rewarding at the neurochemical level.
The neuroscience underlying this concern is straightforward but sobering. Nicotine and cannabis both activate the brain’s reward circuitry, reinforcing the desire to use them repeatedly. Vaping may intensify this reinforcement loop because, unlike smoking a cigarette from start to finish, vaping allows users to take individual puffs scattered throughout the day. Each puff is another opportunity for the drug to engage the reward system, and each engagement is another chance for the behavior to be woven into daily routines and habitual patterns. Amanda Palmer, a Hollings researcher and lead author of the perspective, noted that the products reward people for engaging in an already rewarding behavior, a combination she described as standing out sharply against the logic of treatment. Tracy Smith, an addiction scientist who co-leads the Cancer Prevention and Control Research Program at Hollings, was blunter, saying that the idea of financially incentivizing nicotine use is genuinely frightening given how addictive nicotine is.
Critically, the reward structures of these devices do not incentivize quitting. Points accumulated through vaping can be exchanged for cryptocurrency or used to purchase refill cartridges, which means the rewards feed directly back into further consumption. Palmer described this as a self-sustaining system with no incentive for abstaining, one that keeps users continuously engaged with the product. The concept of rewarding tobacco use is not entirely new, of course. Tobacco companies spent decades cultivating brand loyalty through rewards programs and promotional giveaways, most famously schemes like Camel Cash and Marlboro Miles, which allowed smokers to collect coupons redeemable for merchandise. What distinguishes the current generation of smart vapes is the technological amplification of that old playbook. By combining classic tobacco marketing tactics with smartphone connectivity, cryptocurrency, and game-like mechanics that monitor behavior and reward persistence, these devices achieve a degree of behavioral engineering that earlier loyalty programs could never approach.
The researchers emphasize that this approach diverges fundamentally from evidence-based cessation science. Financial incentives do have a legitimate and well-documented role in helping people quit tobacco, but only when those incentives reward abstinence or healthy behaviors rather than continued substance use. Contingency management programs, for example, have repeatedly demonstrated effectiveness by paying people for verified periods of not using drugs. The vape-to-earn model inverts this architecture entirely, converting each puff into a microtransaction and each session into an earning opportunity. In doing so, it weaponizes one of the most reliable tools in behavioral medicine against the very populations that tool was designed to help, and it does so with a consumer product that requires no prescription, no oversight, and no clinical framing whatsoever.
Perhaps the most acute concern raised in the perspective is the likely appeal of these products to adolescents and young adults. The marketing of smart vapes resembles that of a technology or gaming platform far more than a traditional vaping device, and the deliberate use of artificial intelligence, mobile apps, financial rewards, and game-like features is intended to maximize user engagement. Benjamin Toll, co-director of the Lung Cancer Screening Program and director of the Tobacco Treatment Program at Hollings, expressed particular alarm about the cannabis product, observing that its positioning at the intersection of AI, cryptocurrency, and cannabis produces features that are highly engaging for young people and deeply concerning given the vulnerability of children, adolescents, and young adults whose brains are still developing and especially sensitive to rewarding experiences. The researchers also worry about people experiencing financial hardship, who may be drawn by the promise of earning money or digital assets through vaping, and about individuals with substance use disorders, for whom reward-based recovery programs could be dangerously confused with products that reward the opposite behavior.
Regulation, the paper argues, has failed to keep pace with the technology. In the United States, manufacturers of nicotine vaping products must demonstrate to the Food and Drug Administration that their products are appropriate for the protection of public health before they can be legally marketed. Neither of the smart vaping products examined in the perspective has received FDA authorization, which means they are not legally authorized for sale, yet unauthorized vaping products remain widely available across the country. Smith described the agency’s dilemma bluntly: thousands of unauthorized vaping products are flooding the market, and while the FDA can pursue enforcement against specific companies, it cannot match the sheer scale of the current influx. The FDA has previously prioritized enforcement against products designed to appeal to youth, including devices resembling toys or gaming hardware, and the researchers contend that nicotine products rewarding vaping through cryptocurrency and gamification deserve precisely the same scrutiny.
Cannabis products present an even thornier regulatory problem. Unlike tobacco, there is no federal agency charged with overseeing cannabis products nationwide. Regulation instead varies from state to state, and existing frameworks tend to concentrate on how cannabis products are manufactured and sold rather than on how they are marketed or designed. Palmer noted that there is no equivalent federal oversight system for cannabis and that cannabis regulatory science is not as mature as tobacco regulatory science, which makes emerging technologies of this kind especially difficult to address. The devices raise a further concern that sits outside traditional drug regulation altogether: because they connect to smartphone apps, they collect detailed data about user behavior, and it remains unclear how that information could ultimately be used, monetized, or shared. A device that logs when, where, and how often a person consumes nicotine or cannabis is also a device holding a granular behavioral profile of a potentially vulnerable consumer.
The researchers are careful to draw a distinction between their concerns about vape-to-earn products and opposition to harm reduction or technological innovation more broadly. Electronic cigarettes do expose users to fewer harmful chemicals than combustible cigarettes, and vaping cannabis may reduce exposure to toxins compared with smoking it. The problem is not the hardware but the incentive architecture layered on top of it, which threatens to make addictive substances harder to quit precisely when cessation support is most needed. Palmer explained that the team published the perspective now because researchers and regulators have a rare window to act before these products become commonplace, adding that the vaping marketplace changes incredibly quickly and that careful thought is needed about how such technologies are designed and marketed. The authors hope the paper raises awareness among clinicians and parents about the changing nature of vaping products, encouraging clinicians in particular to stay informed about emerging devices their adolescent and young adult patients may be using. At a minimum, they believe vape-to-earn products should undergo careful review by federal and state regulators, and they hope to spark a broader conversation about how emerging technologies, financial incentives, and addictive substances intersect, and about the need for policy to evolve quickly enough to protect public health. For anyone seeking to quit nicotine, evidence-based tobacco cessation treatments remain highly effective, and comprehensive programs such as MUSC Health’s Tobacco Treatment Program continue to offer support grounded in science rather than in cryptocurrency payouts.
Subject of Research: Smart vaping devices that reward use with cryptocurrency and gamification and their public health risks
Article Title: Getting paid to vape? Researchers say that’s a dangerous combination
Article References: Getting paid to vape? Researchers say that’s a dangerous combination. (n.d.). Original publication
Image Credits: AI Generated
DOI: Not provided
Keywords: vaping, e-cigarettes, nicotine, cryptocurrency, gamification, addiction, cannabis, FDA regulation, public health, smart devices, smoking cessation, adolescent health
Cite Scienmag News
APA
MLA
Chicago
Denise Maddox. (September 26, 2026). Vape-to-Earn Devices Pay Users in Crypto, and Scientists Warn of a New Addiction Trap. Scienmag. https://scienmag.com/vape-to-earn-devices-pay-users-in-crypto-and-scientists-warn-of-a-new-addiction-trap/
Denise Maddox. “Vape-to-Earn Devices Pay Users in Crypto, and Scientists Warn of a New Addiction Trap.” Scienmag, 26 September 2026, https://scienmag.com/vape-to-earn-devices-pay-users-in-crypto-and-scientists-warn-of-a-new-addiction-trap/. Accessed 26 September 2026.
Denise Maddox. “Vape-to-Earn Devices Pay Users in Crypto, and Scientists Warn of a New Addiction Trap.” Scienmag. September 26, 2026. https://scienmag.com/vape-to-earn-devices-pay-users-in-crypto-and-scientists-warn-of-a-new-addiction-trap/
Copy citation
Download RIS
Tags: addictionadolescent healthadolescent vaping and addictionartificial intelligence in vaping devicescannabiscannabis vaping and health implicationscryptocurrencye-cigarettesFDA regulationgamificationgamification of nicotine and cannabis consumptionimpact of crypto incentivized vaping on youthmedical perspectives on vaping device innovationnicotinenicotine dependence and smoking cessationnovel addiction traps in digital healthPublic healthpublic health risks of addictive vaping technologyregulation challenges for vape-to-earn productssmart devicessmart vaping devices and mobile app integrationsmoking cessationVape-to-Earn cryptocurrency rewardsvaping
